Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that it has entered into research agreements with Stanford University and LifeGen Technologies, a genomics company based in Madison, Wis. LifeGen co-founders, Richard Weindruch, Ph.D., and Tomas Prolla, Ph.D., will also hold positions on the newly formed Nu Skin Anti-aging Scientific Advisory Board.
"Nu Skin has established a 25-year legacy of product innovation and our research agreements with Stanford University and LifeGen Technologies add significant fuel to our scientific engine," said Joseph Chang, Ph.D., Nu Skin chief scientific officer and executive vice president of product development. "We believe that these collaborative relationships will help us develop next-generation skin care and nutritional products from an enhanced understanding of the genetic basis of aging."
Research shows brain synchronization between humans and dogs